Interpharm manufactures 100% of their products on-site, thus assuring control and conformance to Interpharm's high quality and standards. The products include tablets, capsules and packages in multiple-unit containers, screw capped bottles and bulk pouches. In addition to Interpharm's core customer base that buys Interpharm's products directly, there is also a growing segment of private label customers, as well as bulk finished product repackagers. The plant layout provides separate areas for receiving, quarantined components, released components, manufacturing, packaging, warehousing and QA/QC testing. The typical process flow, where applicable, is as follows: All manufacturing and packaging equipment is constructed of high quality pharmaceutical grade materials and are designed to facilitate cleaning, maintenance and optimum performance. The Quality Control Laboratory utilizes current methods of analysis and state of the art instrumentation to test and evaluate incoming components, in-process and finished products in accordance with customer, FDA and cGMP requirements. The laboratory also oversees a modern, large-scale product stability and retention program not only for the purpose of regulatory compliance but also for ongoing quality monitoring and continuous improvement of products.
MedPharm provides a full range of pharmaceuticals, diagnostic equipment and water treatment systems to NGOs and UN organizations operating in areas of conflict and in post-war relief and reconstruction activities such as those in Afghanistan , Palestine , Philippines and Iraq . In response to the Tsunami disaster of December 2004, MedPharm in cooperation with its NGO clients, the UN and the DOD, provided pharmaceuticals, diagnostic equipment and water treatment systems in numerous airlift shipments to India , Sri Lanka and Indonesia. Through its subsidiary, MedPharm Europe, MedPharm contract manufactures key essential drugs in Europe under the MedPharm label. It also procures and supplies over 300 generic drugs from leading European manufacturers, including all the drugs listed on the WHO Essential Drugs List. MedPharm, working with its Dutch partner, has the strategic advantage of a new pharmaceutical consolidation facility in Holland with state-of-the-art equipment to assure quality control. Here several hundred pharmaceutical products and medical supplies are consolidated, stored and packaged for export. The pharmaceutical products from Europe meet full GMP and international quality standards (USP, BP, and EP Pharmacopoeia). All pharmaceuticals are fresh stock with full shelf life (18 months to 4 years until expiry date).
At Novopharm our global strength, and access to the largest pool of research and development resources, allow us to provide you with more new products than any other generic pharmaceutical company. In fact, we are the leading Canadian generic company in both the number and brand value of new product submissions. We will continue to lead the industry to strengthen the generic pharmaceutical industry in Canada. With expanding facilities, new products and high ambitions, Novopharm will remain a leader in the generic pharmaceutical industry. We appreciate your support, and again, welcome to Novopharm.com.
Interpharm currently develops, manufactures and distributes generic prescription strength and over-the-counter pharmaceutical products. Interpharm will continue to focus on growing organically through internal product development and leveraging its strength in efficient and cost effective manufacturing. In addition, Interpharm will also continue to seek consummation of mutually beneficial strategic alliances and collaborations.
About PLIVA: With more than 80 years of experience in the pharmaceuticals arena, PLIVA has successfully transformed itself into a multinational corporation, with operations in CEE, the US and Western Europe. The company's vision is to be a research driven, fully integrated global pharmaceutical company dedicated to providing innovative products for a better quality of life. PLIVA is currently the largest CEE headquartered pharmaceutical company by sales, whose most prominent discovery is the blockbuster antibiotic azithromycin, sold under the trademarks of Zithromax and Sumamed.
Actavis is one of the world's leading players in the development, manufacture, and sale of first-class generic pharmaceuticals. Founded in 1956, the Company has led an assertive programme of expansion, making more than 20 acquisitions in the past seven years while maintaining strong organic growth. The Group has approximately 11,000 employees operating in about 40 countries around the globe.
Privacy Policy | Terms and Conditions | Do Not Sell My Personal Information | Websites Directory
Copyright © 2022 kwtbox.com. All Rights Reserved. US Business Directory